N-cadherin expression was previously described in a subset of WHO grade I meningiomas [47] and co-expression of vimentin and N-cadherin was also found in drug-resistant lung cancer [48] and pancreatic carcinoma [49]. Here, VIM is linked to lung carcinoma.